Fingerprinting heterocellular β-adrenoceptor functional expression in the brain using agonist activity profiles

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Noradrenergic pathways from the locus coeruleus regulate critical brain functions like arousal, attention, mood, and memory.
• The specific roles of different adrenoceptors (ARs) in various brain cell types are not fully understood, especially concerning agonist activity.
• Understanding AR function is crucial for developing therapies for neurodegenerative diseases associated with locus coeruleus decline.

Purpose of the Study:

• To pharmacologically characterize brain adrenoceptor (AR) function using novel agonist activity metrics.
• To assess beta-adrenoceptor (β-AR) subtype expression and potential ligand bias across human brain cell systems.
• To provide insights for therapeutic interventions targeting noradrenergic pathways in neurodegenerative conditions.

Main Methods:

• Measured β-AR agonist activities in recombinant cell systems and compared them to isoprenaline to derive system-independent Δlog(Emax/EC50) values.
• Utilized Δlog(Emax/EC50) values as receptor subtype fingerprints to assess expression in human brain cell systems.
• Investigated β-arrestin activation and cAMP response desensitization to evaluate potential ligand bias among β-AR agonists.

Main Results:

• Confirmed that Δlog(Emax/EC50) agonist activity profiles are system-independent, serving as reliable receptor fingerprints.
• Demonstrated functional β2-adrenoceptor (β2-AR) expression across multiple human brain cell types.
• Found no evidence of ligand bias for tested β-AR agonists concerning homologous receptor desensitization in the examined systems.

Conclusions:

• Functional β2-AR expression in diverse human brain cells supports the role of locus coeruleus noradrenergic tone in neuroexcitation and homeostasis.
• The Δlog(Emax/EC50) agonist fingerprinting method is a robust tool for assessing receptor subtype expression.
• This methodology can be applied to study novel ligands and receptors in various tissues, aiding drug discovery for neurological disorders.